NASDAQ · STSS
Healthcare · Medical - Instruments & Supplies
$1.84
Down-$0.03 (-2.31%)
Updated Aug 14, 2026, 12:08 AM
SID Score
5.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance
1M range · 0 trading sessions · Daily adjusted prices
STSS does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
The latest Smart Investors Daily articles mentioning STSS.
STSS research
Company profile and research snapshot.
Sharps Technology Inc is a medical device company. It offers syringes and other safety products. Sharps provensa, Securgard, and Sologard are ultra-low waste smart safety syringes designed to eliminate potentially infectious and accidental needlestick injuries.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| May 9, 2023 | Aegis Capital | Buy | — |
No generated briefing is available yet.
Benzinga · Apr 6, 2026
Sharps Technology (NASDAQ:STSS) reported quarterly earnings of $1.11 per share which beat the analyst consensus estimate of $(0.65) by 270.77 percent. This is a 100.13 percent increase over losses of $(861.00) per share
Benzinga · Apr 6, 2026
Sharps Technology, Inc. ("Sharps" or the "Company"), a medical device sales and distribution company that has adopted a Solana-based digital asset treasury strategy, has announced financial results for the year ended
Benzinga · Feb 25, 2026
Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana digital asset treasury strategy, and The Tie, Inc. ("The Tie"), the leading provider of institutional-grade digital
Benzinga · Feb 5, 2026
Sharps Technology, Inc. ("STSS" or the "Company") (NASDAQ:STSS), a medical device company with a Solana (SOL) digital asset treasury strategy, and BitGo Bank & Trust, National Association ("BitGo"), the digital asset
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning STSS.
